UPDATE: Mallinckrodt Says Planned Separation Of Specialty Generics Unit To Be Executed Through Pro-Rata Distribution Of Common Stock To Co.'s Shareholders; Spin Off Expected To Be Completed In 2H'19 Or Sooner